<p>Prospera Financial Services Inc 在最近向美國證券交易委員會提交的 13F 表格中表示，在第三季度將其在 Intuitive Surgical, Inc.（納斯達克：ISRG - 免費報告）的持股減少了 65.8%。該公司在本季度出售了 13,590 股後，持有 7,063 股該醫療設備提供商的股票。根據其最近向美國證券交易委員會的提交，Prospera Financial Services Inc 在 Intuitive Surgical 的持股價值為 3,159,000 美元。</p>
<p>獲取 <strong>Intuitive Surgical</strong> 警報：</p>
<ul>
<li>超越生物技術——3 只適合成長型投資者的醫療股</li>
</ul>
<p>其他幾家機構投資者也調整了他們對 ISRG 的持股。Brighton Jones LLC 在第四季度將其在 Intuitive Surgical 的股份增加了 24.9%。Brighton Jones LLC 現在擁有 3,672 股該醫療設備提供商的股票，價值 1,916,000 美元，此前在該期間內又購買了 731 股。Sivia Capital Partners LLC 在第二季度將其在 Intuitive Surgical 的持股增加了 3.8%。Sivia Capital Partners LLC 現在擁有 928 股該醫療設備提供商的股票，價值 504,000 美元，此前在該期間內又獲得了 34 股。Moran Wealth Management LLC 在第二季度將其在 Intuitive Surgical 的持股增加了 44.0%。Moran Wealth Management LLC 現在擁有 2,476 股該醫療設備提供商的股票，價值 1,345,000 美元，此前在上個季度又獲得了 757 股。RFG Advisory LLC 在第二季度將其在 Intuitive Surgical 的持股增加了 4.2%。RFG Advisory LLC 現在擁有 3,374 股該醫療設備提供商的股票，價值 1,833,000 美元，此前在上個季度又獲得了 136 股。最後，Bayforest Capital Ltd 在第二季度獲得了 Intuitive Surgical 的新頭寸，價值 199,000 美元。機構投資者持有該公司 83.64% 的股票。</p>
<h2>Intuitive Surgical 價格表現</h2>
<p>納斯達克 ISRG 週五開盤價為 478.60 美元。該公司的 50 日簡單移動平均線為 543.41 美元，200 日簡單移動平均線為 510.30 美元。Intuitive Surgical, Inc. 的 12 個月低點為 425.00 美元，12 個月高點為 609.08 美元。該公司的市值為 1699.7 億美元，市盈率為 60.66，PEG 比率為 3.84，貝塔係數為 1.65。</p>
<ul>
<li>Intuitive Surgical 剛剛證明增長引擎仍在運轉</li>
</ul>
<p>Intuitive Surgical（納斯達克：ISRG - 獲取免費報告）最近於 1 月 22 日星期四發佈了其財報。該醫療設備提供商報告本季度每股收益為 2.53 美元，超出分析師一致預期的 2.27 美元，超出幅度為 0.26 美元。該公司本季度的收入為 28.7 億美元，而分析師預期為 27.2 億美元。Intuitive Surgical 的淨利潤率為 28.38%，股本回報率為 15.06%。該公司本季度的收入較去年同期增長了 18.8%。去年同期，該公司每股收益為 2.21 美元。分析師預計 Intuitive Surgical, Inc. 本年度將發佈每股收益 6.43 美元。</p>
<h2>分析師設定新目標價</h2>
<p>多家券商最近對 ISRG 進行了評估。Zacks Research 在 1 月 21 日的研究報告中將 Intuitive Surgical 的股票評級從 &#34;強力買入&#34; 下調至 &#34;持有&#34;。Weiss Ratings 在 12 月 29 日的研究報告中重申了對 Intuitive Surgical 股票的 &#34;持有（c+）&#34; 評級。Argus 在 2 月 4 日的研究報告中將 Intuitive Surgical 的目標價從 630.00 美元下調至 560.00 美元，並對該公司設定了 &#34;買入&#34; 評級。BTIG Research 在 1 月 23 日的報告中重申了 &#34;買入&#34; 評級，並對 Intuitive Surgical 的股票設定了 616.00 美元的目標價。最後，滙豐銀行在 1 月 26 日的報告中將 Intuitive Surgical 的目標價從 644.00 美元上調至 653.00 美元，並給予該股票 &#34;買入&#34; 評級。1 位分析師對該股票給予了強力買入評級，15 位給予了買入評級，8 位給予了持有評級，1 位給予了賣出評級。根據 MarketBeat 的數據，該股票的平均評級為 &#34;適度買入&#34;，平均目標價為 617.23 美元。</p>
<ul>
<li>2 只醫療股可能因財報而獲得大幅提振</li>
</ul>
<p><strong>閲讀我們關於 ISRG 的最新研究報告</strong></p>
<h2>內部買賣情況</h2>
<p>在其他新聞中，SVP Mark Brosius 於 12 月 12 日星期五出售了 4,500 股公司的股票。該股票以平均價格 547.36 美元出售，總交易額為 2,463,120.00 美元。出售完成後，該高級副總裁直接持有 907 股公司的股票，價值 496,455.52 美元。這代表其持股減少了 83.23%。該交易已在向美國證券交易委員會提交的文件中披露，文件可在美國證券交易委員會網站上獲取。此外，副總裁 Fredrik Widman 於 2 月 11 日星期三出售了 133 股該股票。該股票以平均價格 494.96 美元出售，總價值為 65,829.68 美元。交易完成後，該副總裁持有 660 股公司的股票，價值 326,673.60 美元。該交易的披露信息可在美國證券交易委員會的文件中找到。在上個季度，內部人士共出售了價值 30,785,441 美元的 56,189 股公司股票。內部人士持有該公司 0.70% 的股票。</p>
<h2>影響 Intuitive Surgical 的關鍵頭條新聞</h2>
<p>以下是本週影響 Intuitive Surgical 的關鍵新聞故事：</p>
<ul>
<li>積極情緒：公司基本面：直覺外科在一月季度的收入和每股收益超出預期，管理層強調了持續的手術增長和 da Vinci 5 的採用——這提醒我們增長引擎依然完好。閲讀更多。</li>
<li>積極情緒：分析師支持：經紀人社區整體仍然偏向積極（許多買入/增持評級和幾次目標價上調），這為執行持續提供了底線。閲讀更多。</li>
<li>中性情緒：技術面和資金流動：交易者關注最近相對於 50 日和 200 日移動平均線的回調；即使基本面穩定，技術定位也可能放大短期波動。閲讀更多。</li>
<li>中性情緒：最近的空頭頭寸報告顯示異常的零/NaN 值，應謹慎對待——它們似乎無法解釋今天的走勢。</li>
<li>消極情緒：內部人士賣出：多位內部人士在二月初披露的銷售（執行副總裁 Myriam Curet 和副總裁 Fredrik Widman）引發了短期消極情緒，可能被解讀為獲利了結。閲讀更多。閲讀更多。</li>
<li>消極情緒：估值和近期表現不佳：覆蓋分析質疑 ISRG 是否 “定價完美”，在回調和約 13% 的三個月下跌後，儘管業績超出預期，仍讓一些投資者保持謹慎。閲讀更多。閲讀更多。</li>
</ul>
<h2>關於直覺外科</h2>
<p>（免費報告）</p>
<p>直覺外科成立於 1995 年，總部位於加利福尼亞州陽光谷，是一家專注於機器人輔助手術系統設計、製造和服務的醫療技術公司。該公司以其 da Vinci 手術系統而聞名，該系統通過將外科醫生的手部動作轉化為患者體內小型儀器的更精細、縮放的運動，從而實現微創手術。直覺的業務集中在向醫院和手術中心提供系統、儀器和相關技術，旨在提高手術室的精確度、可視化和控制能力。</p>
<p>除了核心手術平台外，直覺還銷售一系列可重複使用和一次性使用的儀器、配件和專有軟件，併為客户提供培訓、服務和臨牀支持。</p>
<h2>精選故事</h2>
<ul>
<li>五隻我們認為比直覺外科更好的股票</li>
<li>Nvidia CEO 發佈大膽的特斯拉預測</li>
<li>你的銀行賬户不再安全</li>
<li>在 2026 年 5 月之前購買這隻黃金股票</li>
<li>一位前 CIA 特工對即將到來的崩潰的看法</li>
<li>新的黃金價格目標</li>
</ul>
<p><strong>想看看其他對 ISRG 持有的對沖基金嗎？</strong> 訪問 HoldingsChannel.com，獲取直覺外科公司（NASDAQ:ISRG - 免費報告）的最新 13F 文件和內部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 1000 美元在直覺外科嗎？</h2>
<p>在考慮直覺外科之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄建議客户現在購買的股票，而直覺外科並不在名單上。</p>
<p>雖然直覺外科目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

標普健康醫療設備 ETF - SPDR

ISUL

直覺外科

美國醫藥設備 ETF - iShares

<p>Prospera Financial Services Inc 在第三季度減少了對 Intuitive Surgical, Inc. (NASDAQ:ISRG) 的持股比例，降幅為 65.8%，目前持有 7,063 股，市值為 316 萬美元。其他機構投資者也調整了他們的持倉，Brighton Jones LLC 增加了 24.9% 的持股。Intuitive Surgical 的股票開盤價為 478.60 美元，市值為 1699.7 億美元，市盈率為 60.66。分析師對該股票的評級不一，平均目標價為 617.23 美元</p>

<p>Prospera Financial Services Inc decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 65.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 7,063 shares of the medical equipment provider's stock after selling 13,590 shares during the quarter. Prospera Financial Services Inc's holdings in Intuitive Surgical were worth $3,159,000 as of its most recent filing with the SEC.</p>
<div class="lb-trans"><p>Prospera Financial Services Inc 在最近向美國證券交易委員會提交的 13F 表格中表示，在第三季度將其在 Intuitive Surgical, Inc.（納斯達克：ISRG - 免費報告）的持股減少了 65.8%。該公司在本季度出售了 13,590 股後，持有 7,063 股該醫療設備提供商的股票。根據其最近向美國證券交易委員會的提交，Prospera Financial Services Inc 在 Intuitive Surgical 的持股價值為 3,159,000 美元。</p>
</div><p>Get <strong>Intuitive Surgical</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Intuitive Surgical</strong> 警報：</p>
</div><ul>
<li>Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>超越生物技術——3 只適合成長型投資者的醫療股</li>
</ul>
</div><p>Several other institutional investors have also modified their holdings of ISRG. Brighton Jones LLC increased its stake in shares of Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock valued at $1,916,000 after purchasing an additional 731 shares during the period. Sivia Capital Partners LLC increased its position in Intuitive Surgical by 3.8% in the 2nd quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider's stock valued at $504,000 after acquiring an additional 34 shares during the period. Moran Wealth Management LLC raised its stake in Intuitive Surgical by 44.0% during the 2nd quarter. Moran Wealth Management LLC now owns 2,476 shares of the medical equipment provider's stock valued at $1,345,000 after acquiring an additional 757 shares in the last quarter. RFG Advisory LLC raised its stake in Intuitive Surgical by 4.2% during the 2nd quarter. RFG Advisory LLC now owns 3,374 shares of the medical equipment provider's stock valued at $1,833,000 after acquiring an additional 136 shares in the last quarter. Finally, Bayforest Capital Ltd acquired a new position in Intuitive Surgical during the 2nd quarter worth $199,000. Institutional investors own 83.64% of the company's stock.</p>
<div class="lb-trans"><p>其他幾家機構投資者也調整了他們對 ISRG 的持股。Brighton Jones LLC 在第四季度將其在 Intuitive Surgical 的股份增加了 24.9%。Brighton Jones LLC 現在擁有 3,672 股該醫療設備提供商的股票，價值 1,916,000 美元，此前在該期間內又購買了 731 股。Sivia Capital Partners LLC 在第二季度將其在 Intuitive Surgical 的持股增加了 3.8%。Sivia Capital Partners LLC 現在擁有 928 股該醫療設備提供商的股票，價值 504,000 美元，此前在該期間內又獲得了 34 股。Moran Wealth Management LLC 在第二季度將其在 Intuitive Surgical 的持股增加了 44.0%。Moran Wealth Management LLC 現在擁有 2,476 股該醫療設備提供商的股票，價值 1,345,000 美元，此前在上個季度又獲得了 757 股。RFG Advisory LLC 在第二季度將其在 Intuitive Surgical 的持股增加了 4.2%。RFG Advisory LLC 現在擁有 3,374 股該醫療設備提供商的股票，價值 1,833,000 美元，此前在上個季度又獲得了 136 股。最後，Bayforest Capital Ltd 在第二季度獲得了 Intuitive Surgical 的新頭寸，價值 199,000 美元。機構投資者持有該公司 83.64% 的股票。</p>
</div><h2>Intuitive Surgical Price Performance</h2>
<div class="lb-trans"><h2>Intuitive Surgical 價格表現</h2>
</div><p>NASDAQ ISRG opened at $478.60 on Friday. The company's 50 day simple moving average is $543.41 and its 200 day simple moving average is $510.30. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $609.08. The company has a market capitalization of $169.97 billion, a P/E ratio of 60.66, a PEG ratio of 3.84 and a beta of 1.65.</p>
<div class="lb-trans"><p>納斯達克 ISRG 週五開盤價為 478.60 美元。該公司的 50 日簡單移動平均線為 543.41 美元，200 日簡單移動平均線為 510.30 美元。Intuitive Surgical, Inc. 的 12 個月低點為 425.00 美元，12 個月高點為 609.08 美元。該公司的市值為 1699.7 億美元，市盈率為 60.66，PEG 比率為 3.84，貝塔係數為 1.65。</p>
</div><ul>
<li>Intuitive Surgical Just Proved the Growth Engine Still Runs</li>
</ul>
<div class="lb-trans"><ul>
<li>Intuitive Surgical 剛剛證明增長引擎仍在運轉</li>
</ul>
</div><p>Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping analysts' consensus estimates of $2.27 by $0.26. The firm had revenue of $2.87 billion during the quarter, compared to analysts' expectations of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The firm's revenue for the quarter was up 18.8% compared to the same quarter last year. During the same period last year, the firm posted $2.21 earnings per share. On average, analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.</p>
<div class="lb-trans"><p>Intuitive Surgical（納斯達克：ISRG - 獲取免費報告）最近於 1 月 22 日星期四發佈了其財報。該醫療設備提供商報告本季度每股收益為 2.53 美元，超出分析師一致預期的 2.27 美元，超出幅度為 0.26 美元。該公司本季度的收入為 28.7 億美元，而分析師預期為 27.2 億美元。Intuitive Surgical 的淨利潤率為 28.38%，股本回報率為 15.06%。該公司本季度的收入較去年同期增長了 18.8%。去年同期，該公司每股收益為 2.21 美元。分析師預計 Intuitive Surgical, Inc. 本年度將發佈每股收益 6.43 美元。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析師設定新目標價</h2>
</div><p>A number of brokerages recently weighed in on ISRG. Zacks Research cut shares of Intuitive Surgical from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research note on Wednesday, January 21st. Weiss Ratings reissued a &#34;hold (c+)&#34; rating on shares of Intuitive Surgical in a research note on Monday, December 29th. Argus reduced their price target on shares of Intuitive Surgical from $630.00 to $560.00 and set a &#34;buy&#34; rating for the company in a research note on Wednesday, February 4th. BTIG Research reiterated a &#34;buy&#34; rating and issued a $616.00 price objective on shares of Intuitive Surgical in a report on Friday, January 23rd. Finally, HSBC boosted their target price on Intuitive Surgical from $644.00 to $653.00 and gave the stock a &#34;buy&#34; rating in a report on Monday, January 26th. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the stock has an average rating of &#34;Moderate Buy&#34; and an average price target of $617.23.</p>
<div class="lb-trans"><p>多家券商最近對 ISRG 進行了評估。Zacks Research 在 1 月 21 日的研究報告中將 Intuitive Surgical 的股票評級從 &#34;強力買入&#34; 下調至 &#34;持有&#34;。Weiss Ratings 在 12 月 29 日的研究報告中重申了對 Intuitive Surgical 股票的 &#34;持有（c+）&#34; 評級。Argus 在 2 月 4 日的研究報告中將 Intuitive Surgical 的目標價從 630.00 美元下調至 560.00 美元，並對該公司設定了 &#34;買入&#34; 評級。BTIG Research 在 1 月 23 日的報告中重申了 &#34;買入&#34; 評級，並對 Intuitive Surgical 的股票設定了 616.00 美元的目標價。最後，滙豐銀行在 1 月 26 日的報告中將 Intuitive Surgical 的目標價從 644.00 美元上調至 653.00 美元，並給予該股票 &#34;買入&#34; 評級。1 位分析師對該股票給予了強力買入評級，15 位給予了買入評級，8 位給予了持有評級，1 位給予了賣出評級。根據 MarketBeat 的數據，該股票的平均評級為 &#34;適度買入&#34;，平均目標價為 617.23 美元。</p>
</div><ul>
<li>2 Healthcare Names That Could Get a Big Boost From Earnings</li>
</ul>
<div class="lb-trans"><ul>
<li>2 只醫療股可能因財報而獲得大幅提振</li>
</ul>
</div><p><strong>Read Our Latest Research Report on ISRG</strong></p>
<div class="lb-trans"><p><strong>閲讀我們關於 ISRG 的最新研究報告</strong></p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>內部買賣情況</h2>
</div><p>In other news, SVP Mark Brosius sold 4,500 shares of the company's stock in a transaction on Friday, December 12th. The stock was sold at an average price of $547.36, for a total transaction of $2,463,120.00. Following the completion of the sale, the senior vice president directly owned 907 shares of the company's stock, valued at $496,455.52. This represents a 83.23% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, VP Fredrik Widman sold 133 shares of the stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total value of $65,829.68. Following the completion of the transaction, the vice president owned 660 shares of the company's stock, valued at $326,673.60. This trade represents a 16.77% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 56,189 shares of company stock valued at $30,785,441. Insiders own 0.70% of the company's stock.</p>
<div class="lb-trans"><p>在其他新聞中，SVP Mark Brosius 於 12 月 12 日星期五出售了 4,500 股公司的股票。該股票以平均價格 547.36 美元出售，總交易額為 2,463,120.00 美元。出售完成後，該高級副總裁直接持有 907 股公司的股票，價值 496,455.52 美元。這代表其持股減少了 83.23%。該交易已在向美國證券交易委員會提交的文件中披露，文件可在美國證券交易委員會網站上獲取。此外，副總裁 Fredrik Widman 於 2 月 11 日星期三出售了 133 股該股票。該股票以平均價格 494.96 美元出售，總價值為 65,829.68 美元。交易完成後，該副總裁持有 660 股公司的股票，價值 326,673.60 美元。該交易的披露信息可在美國證券交易委員會的文件中找到。在上個季度，內部人士共出售了價值 30,785,441 美元的 56,189 股公司股票。內部人士持有該公司 0.70% 的股票。</p>
</div><h2>Key Headlines Impacting Intuitive Surgical</h2>
<div class="lb-trans"><h2>影響 Intuitive Surgical 的關鍵頭條新聞</h2>
</div><p>Here are the key news stories impacting Intuitive Surgical this week:</p>
<div class="lb-trans"><p>以下是本週影響 Intuitive Surgical 的關鍵新聞故事：</p>
</div><ul>
<li>Positive Sentiment: Company fundamentals: Intuitive beat January quarter revenue and EPS estimates and management highlighted continued procedure growth and da Vinci 5 adoption — a reminder the growth engine remains intact. Read More.</li>
<li>Positive Sentiment: Analyst support: The broker community still leans positive overall (many Buy/Overweight ratings and several price-target raises), which provides a floor if execution continues. Read More.</li>
<li>Neutral Sentiment: Technicals and flow: Traders are focused on the recent pullback vs. 50‑ and 200‑day moving averages; technical positioning can amplify near‑term moves even if fundamentals are stable. Read More.</li>
<li>Neutral Sentiment: Short‑interest reports in recent feeds show anomalous zero/NaN values and should be treated with caution — they don’t appear to explain today’s move.</li>
<li>Negative Sentiment: Insider selling: Multiple insider sales disclosed in early February (EVP Myriam Curet and VP Fredrik Widman) are prompting short‑term negative sentiment and may be interpreted as profit‑taking. Read More. Read More.</li>
<li>Negative Sentiment: Valuation and recent underperformance: Coverage questioning whether ISRG is “priced for perfection” after a pullback and a ~13% three‑month decline is keeping some investors cautious despite the beat. Read More. Read More.</li>
</ul>
<div class="lb-trans"><ul>
<li>積極情緒：公司基本面：直覺外科在一月季度的收入和每股收益超出預期，管理層強調了持續的手術增長和 da Vinci 5 的採用——這提醒我們增長引擎依然完好。閲讀更多。</li>
<li>積極情緒：分析師支持：經紀人社區整體仍然偏向積極（許多買入/增持評級和幾次目標價上調），這為執行持續提供了底線。閲讀更多。</li>
<li>中性情緒：技術面和資金流動：交易者關注最近相對於 50 日和 200 日移動平均線的回調；即使基本面穩定，技術定位也可能放大短期波動。閲讀更多。</li>
<li>中性情緒：最近的空頭頭寸報告顯示異常的零/NaN 值，應謹慎對待——它們似乎無法解釋今天的走勢。</li>
<li>消極情緒：內部人士賣出：多位內部人士在二月初披露的銷售（執行副總裁 Myriam Curet 和副總裁 Fredrik Widman）引發了短期消極情緒，可能被解讀為獲利了結。閲讀更多。閲讀更多。</li>
<li>消極情緒：估值和近期表現不佳：覆蓋分析質疑 ISRG 是否 “定價完美”，在回調和約 13% 的三個月下跌後，儘管業績超出預期，仍讓一些投資者保持謹慎。閲讀更多。閲讀更多。</li>
</ul>
</div><h2>About Intuitive Surgical</h2>
<div class="lb-trans"><h2>關於直覺外科</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.</p>
<div class="lb-trans"><p>直覺外科成立於 1995 年，總部位於加利福尼亞州陽光谷，是一家專注於機器人輔助手術系統設計、製造和服務的醫療技術公司。該公司以其 da Vinci 手術系統而聞名，該系統通過將外科醫生的手部動作轉化為患者體內小型儀器的更精細、縮放的運動，從而實現微創手術。直覺的業務集中在向醫院和手術中心提供系統、儀器和相關技術，旨在提高手術室的精確度、可視化和控制能力。</p>
</div><p>In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.</p>
<div class="lb-trans"><p>除了核心手術平台外，直覺還銷售一系列可重複使用和一次性使用的儀器、配件和專有軟件，併為客户提供培訓、服務和臨牀支持。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精選故事</h2>
</div><ul>
<li>Five stocks we like better than Intuitive Surgical</li>
<li>Nvidia CEO Issues Bold Tesla Call</li>
<li>Your Bank Account Is No Longer Safe</li>
<li>Buy this Gold Stock Before May 2026</li>
<li>What a Former CIA Agent Knows About the Coming Collapse</li>
<li>New gold price target</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們認為比直覺外科更好的股票</li>
<li>Nvidia CEO 發佈大膽的特斯拉預測</li>
<li>你的銀行賬户不再安全</li>
<li>在 2026 年 5 月之前購買這隻黃金股票</li>
<li>一位前 CIA 特工對即將到來的崩潰的看法</li>
<li>新的黃金價格目標</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding ISRG?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他對 ISRG 持有的對沖基金嗎？</strong> 訪問 HoldingsChannel.com，獲取直覺外科公司（NASDAQ:ISRG - 免費報告）的最新 13F 文件和內部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=ISRG"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Intuitive Surgical Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在直覺外科嗎？</h2>
</div><p>Before you consider Intuitive Surgical, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮直覺外科之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄建議客户現在購買的股票，而直覺外科並不在名單上。</p>
</div><p>While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然直覺外科目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

Prospera Financial Services Inc 減少了其在直覺外科公司 $ISRG 的頭寸